| 前收市價 | 0.1900 |
| 開市 | 0.1900 |
| 買盤 | 0.1100 |
| 賣出價 | 0.3000 |
| 拍板 | 17.50 |
| 到期日 | 2025-01-17 |
| 今日波幅 | 0.1900 - 0.1900 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 727 |
BenzingaMartin Shkreli Gets Scammed in Crypto Venture by Old Prison Friend, 'Don't Start Crypto Ventures With People You Meet in Prison
Controversial businessman Martin Shkreli, the former CEO of Turing Pharmaceuticals who raised the price of an essential drug from $13.50 to $750 per pill overnight, appears to have gained a new enemy. In a lengthy post on X, Shkreli shares that he "met this kid in prison" who "wanted to remake his life in crypto trading." In what Mr. Shkreli described as a "gesture of friendship", he gifted the friend 5 million tokens of a soon-to-be-released new project Martin Shkreli is working on. Don't Miss:
Insider MonkeyCoinbase Global, Inc. (NASDAQ:COIN) Q1 2024 Earnings Call Transcript
Coinbase Global, Inc. (NASDAQ:COIN) Q1 2024 Earnings Call Transcript May 2, 2024 Coinbase Global, Inc. beats earnings expectations. Reported EPS is $1.04, expectations were $0.02195. Coinbase Global, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. My name […]
Barrons.comThese Stocks Are Moving the Most Today: Apple, Amgen, Expedia, Booking, Block, Cloudflare, Fortinet, and More
Apple reports better-than-estimated earnings and expands its buyback program by $110 billion, Amgen ‘very encouraged’ by preliminary data from a trial of a weight-loss drug, and Expedia reduces its sales outlook for the year.
